RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 83 filers reported holding RAPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,686,133 | -0.4% | 221,789 | +12.1% | 0.00% | 0.0% |
Q2 2023 | $3,699,702 | +3.4% | 197,845 | +1.5% | 0.00% | 0.0% |
Q1 2023 | $3,577,626 | +5.6% | 194,966 | +13.9% | 0.00% | 0.0% |
Q4 2022 | $3,389,503 | -15.4% | 171,187 | +2.8% | 0.00% | 0.0% |
Q3 2022 | $4,006,000 | +44.0% | 166,487 | +9.2% | 0.00% | 0.0% |
Q2 2022 | $2,782,000 | -13.3% | 152,418 | +4.5% | 0.00% | 0.0% |
Q1 2022 | $3,207,000 | -38.6% | 145,818 | +2.6% | 0.00% | -50.0% |
Q4 2021 | $5,219,000 | +19.9% | 142,073 | +1.4% | 0.00% | +100.0% |
Q3 2021 | $4,352,000 | +69.5% | 140,134 | +73.5% | 0.00% | 0.0% |
Q2 2021 | $2,568,000 | +75.2% | 80,760 | +22.4% | 0.00% | 0.0% |
Q1 2021 | $1,466,000 | +11.8% | 66,003 | -0.5% | 0.00% | 0.0% |
Q4 2020 | $1,311,000 | -37.7% | 66,345 | +1.4% | 0.00% | 0.0% |
Q3 2020 | $2,106,000 | +40.2% | 65,397 | +26.4% | 0.00% | 0.0% |
Q2 2020 | $1,502,000 | +138.0% | 51,756 | +74.7% | 0.00% | – |
Q1 2020 | $631,000 | +40.8% | 29,632 | +82.9% | 0.00% | – |
Q4 2019 | $448,000 | – | 16,197 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |